Putin Signs New Order: Food Embargo Extended for Two More Years, Sanctions Continue Until 2026!
Russian President Vladimir Putin has signed a decree extending a food embargo imposed in 2014 in response to international sanctions until 2025 and 2026, Sputnik news agency reported in Moscow. The decree has been officially published on the official website of Russian Legal Information.
"Presidential Decree No. 560 of August 6, 2014, aimed at ensuring the security of the Russian Federation and implementing independent special economic measures, extends the validity period of independent special economic measures from January 1, 2025 to December 31, 2026," the decree states.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-14
-
Functional Ingredients Industry Overview
Collection of Markets for Functional Ingredients in Food & Nutrition and Cosmetics.Published in: Mar. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EU Greenlights Four GM Crops—But Only at the Border
-
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
Japan Tightens Additive Use Standards
-
FDA Tightens the Solvent Side of Natural Color Production
-
China Moves Lycopene Toward Filing-Based Health Food Management
-
March Brought a Faster Global Food Rule Cycle
-
Brazil Rewrites the Supplement Rulebook
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
-
New York Targets Additives and GRAS Disclosure
-
FDA Pushes New Approach to “No Artificial Colors” Claims
Recommend Reading
-
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
Moldova Proposes Stricter Quality Standards for Edible Casein and Caseinates
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
6100 mg Dosage Warning! EU Safety Panel Flags Serious Risks for Magnesium Orotate Dihydrate
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply